ASHLEY LAMB: Open Payments
NPI 1376169516 · CAMDEN, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,812 in 101 payments from 20 companies in 2025. Trend: 2023 $430 · 2024 $1,507 · 2025 $1,812
Food & beverage: $1,812
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $325 |
| Novo Nordisk Inc | 17 | $288 |
| AstraZeneca Pharmaceuticals LP | 7 | $284 |
| Exact Sciences Corporation | 7 | $177 |
| Lilly USA, LLC | 15 | $175 |
| Merck Sharp & Dohme LLC | 5 | $104 |
| PFIZER INC. | 6 | $101 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $77 |
| GlaxoSmithKline, LLC. | 2 | $41 |
| Abbott Laboratories | 2 | $37 |
Products named: QULIPTA, FARXIGA, Ozempic, The Cologuard Plus Collection Kit, VRAYLAR, JARDIANCE, MOUNJARO, VAXELIS.
Industry payments across OH — which companies pay providers there.
